
Sildenafil requires a written prescription from a licensed veterinarian.
Specialty Veterinary Pharmacy does not make any claims of efficacy for this medication. These medications are not an FDA approved item, but are compounded in a licensed pharmacy. SVPMEDS compounds Sildenafil to meet individual patients' needs using USP <795> guidelines.
In May 2020, Aspargo announced the results of its pre-Investigational New Drug (pre-IND) meeting with the United States Food & Drug Administration (FDA), where the FDA addressed Aspargo’s questions and provided guidance on the Company’s Sildenafil Oral Spray for the treatment of erectile dysfunction (ED). The FDA was supportive of a single dose bioequivalent study comparing Aspargo’s Sildenafil Oral Spray, an oral liquid suspension formulation of sildenafil citrate, with VIAGRA® tablets as the basis for approval and deemed the 505(b)(2) regulatory pathway appropriate for the program. “The acquisition of global rights to Sildenafil Oral Spray represents a significant opportunity for Aspargo”, said Michael Demurjian, Aspargo’s Founder and Chief Executive Officer. “The erectile dysfunction market is one of the most expansive categories in the healthcare industry, as men continue to seek a more efficient and convenient solution to address their condition. Following our recent successful completion of a $7.5 million financing, Aspargo has transformed into a rapidly growing global specialty pharmaceutical company.” Aspargo’s oral spray suspension formulation of sildenafil citrate (Sildenafil Oral Spray), the active ingredient in VIAGRA®; is a novel and convenient route of administration for this commonly prescribed medication for erectile dysfunction.
The oral suspension formulation of sildenafil citrate is approved for sale in 9 European countries in a liquid dosage form and in Spain in the spray dosage form; the spray dosage form is undergoing registration in various jurisdictions worldwide, including 8 European countries and 8 Latin American countries. Aspargo’s Sildenafil Oral Spray is protected by US Patent No. 10,016,428 B2 (granted: July 10, 2018); European Patent No. EP3072515 (granted: February 28, 2018); and Russian Patent No. RU2016127223A (granted: April 4, 2018) entitled, Pharmaceutical Composition of Sildenafil Citrate in the Form of a Suspension for Oral Use – and by trade secrets and manufacturing know-how necessary to manufacture the oral spray formulation and to ensure drug stability. Sildenafil oral tablet is available as a brand-name drug and as a generic drug. Sildenafil comes in three forms: an oral tablet, an oral suspension (liquid), and an injection that’s only given by a doctor.
| Product | Dosage | Quantity + Bonus | Price | |
|---|---|---|---|---|
| Kamagra Polo | 100mg | 120 + 6 Pills | 327.15€ 311.57€ | |
| Viagra Generic | 100mg | 10 Pills | 28.91€ 27.53€ | |
| Viagra Generic | 100mg | 60 + 4 Pills | 96.36€ 91.77€ | |
| Kamagra | 100mg | 12 Pills | 55.64€ 52.99€ | |
| Kamagra Polo | 100mg | 60 + 4 Pills | 189.39€ 180.37€ | |
| Kamagra Oral Jelly | 100mg | 63 + 7 Sachets | 224.18€ 213.50€ | |
| Viagra Generic | 100mg | 270 + 10 Pills | 270.47€ 257.59€ | |
| Viagra Generic | 100mg | 180 + 8 Pills | 199.37€ 189.88€ | |
| Kamagra Oral Jelly | 100mg | 90 + 8 Sachets | 303.56€ 289.10€ | |
| Viagra Generic | 50mg | 30 + 4 Pills | 54.26€ 51.68€ | |
| Kamagra Polo | 100mg | 272 + 12 Pills | 622.94€ 593.28€ | |
| Viagra Generic | 50mg | 180 + 8 Pills | 158.82€ 151.26€ |
Sildenafil oral tablet is used to treat erectile dysfunction (ED).
Formulated with 100mg of Sildenafil Citrate—the same active ingredient found in Viagra—this oral jelly works by increasing blood flow to the penile region, enabling a firm and lasting pfizer sildenafil 50 erection when combined with sexual stimulation. The unique jelly consistency is ideal for those who have difficulty swallowing pills. Packaged in discreet, single-use sachets, it can be consumed directly without the need for water. Because it is absorbed through the oral mucosa, it typically takes effect in just 15 to 20 minutes, significantly faster than standard tablets. Available in a variety of pleasant fruit flavors, Kamagra Oral Jelly offers a more enjoyable experience while providing reliable performance for up to 4–6 hours.
It is an excellent choice for restoring confidence and enhancing spontaneity in your intimate life. Sildenafil Oral Liquid compounded for dogs and cats. Sildenafil Citrate oral liquid compounded for dogs and cats could be beneficial for treating pulmonary hypertension in dogs and cats. Sildenafil is available in tablets of 25 mg, 50 mg, and 100 mg strengths. These strengths are very limited when treating dogs, and compounding into dose-specific forms is an option to consider. It’s also used to treat pulmonary arterial hypertension (PAH).
The patent application (Publication Number: US20230381187A1) discloses a ready-to-use liquid oral formulation containing sildenafil citrate at a concentration of about 10 mg/mL, along with pharmaceutically acceptable excipients including a wetting agent like glycerin. The formulation is specified to have a pH ranging from about 4 to 8, with variations in pH levels mentioned in specific claims. Additionally, the formulation may include a buffering agent and anti-foaming agent, along with sildenafil citrate particles and a viscosity-modifying agent comprising water-soluble hydrocolloids.Furthermore, the patent application outlines methods of treating various conditions in humans by administering the disclosed liquid oral formulation. The conditions mentioned include hypertension, pulmonary hypertension, arterial hypertension, pulmonary arterial hypertension, and erectile dysfunction. The stability of the formulation is highlighted, indicating that it remains stable for up to six months when stored under specific conditions.
The presence of impurities in the composition is also limited to ensure product quality and efficacy in treating the specified conditions. To know more about GlobalData’s detailed insights on Zydus Lifesciences, buy the report here. Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors. Kamagra Oral Jelly is a popular and effective alternative to traditional erectile dysfunction (ED) tablets, designed for men who prefer a more convenient and faster-acting solution. It comes in the form of a tablet and suspension (liquid). It also comes in an intravenous (IV) form, which is only given by a doctor. Sildenafil oral tablet is available as the brand-name drugs Viagra and Revatio.
| Condition | Risk Factors | Alternative Recommendations |
|---|---|---|
| Use with nitrates | Severe hypotension | Avoid concomitant use |
| Severe hepatic impairment | Altered drug metabolism | Dose adjustment or alternative therapy |
| Cardiovascular instability | Risk of adverse events | Medical evaluation required |
| Retinitis pigmentosa | Potential retinal toxicity | Consult ophthalmologist |
It’s also available as a generic drug. Generic drugs usually cost less than the brand-name version.
In some cases, they may not be available in every strength or form as the brand-name drug.
Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made, and the facts and assumptions underlying the forward-looking statements may change. Except as required by law, Aspargo disclaims any obligation to update these forward-looking statements to reflect future information, events or circumstances. Click here for the full press release. has filed a patent for a liquid oral formulation containing 10 mg/mL of sildenafil citrate and glycerin as a wetting agent. The formulation is designed for the treatment of conditions like pulmonary arterial hypertension and erectile dysfunction.
GlobalData’s report on Zydus Lifesciences gives a 360-degree view of the company including its patenting strategy. Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms. According to GlobalData’s company profile on Zydus Lifesciences, NSAID cancer drugs was a key innovation area identified from patents. Zydus Lifesciences's grant share as of January 2024 was 32%. Grant share is based on the ratio of number of grants to total number of patents. Generic oral tablets are available for both conditions, but the brand-name drugs each treat only one of the conditions. Viagra: This drug is used to treat ED. With ED, you’re unable to get or maintain an erection.
| Parameter | Value | Description | Notes |
|---|---|---|---|
| Absorption time | 30-60 minutes | Time to reach peak plasma levels | Faster onset compared to tablets |
| Peak plasma concentration | 150-200 ng/mL | Max systemic concentration | Varies per dose and individual |
| Half-life | 4-5 hours | Time to reduce concentration by half | Helps determine dosing intervals |
| Bioavailability | 40-50% | Fraction reaching systemic circulation | Slightly variable across patients |
Revatio: This drug is used to treat PAH.
Aspargo is protecting its custom designed spray bottle with US and international patent applications. About Erectile Dysfunction (ED)Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the persistent difficulty achieving and maintaining an erection sufficient to have sexual intercourse. Common causes of ED include: heart disease, clogged blood vessels (atherosclerosis), high cholesterol, high blood pressure, diabetes, obesity, metabolic syndrome, Parkinson’s disease, Multiple Sclerosis, certain prescription medications, tobacco use, Peyronie’s disease, alcoholism and other forms of substance abuse, sleep disorders, treatments for prostate cancer or enlarged prostate, surgeries or injuries that affect the pelvic area or spinal cord; and low testosterone. Psychological conditions, such as stress, anxiety or depression, can contribute to erectile dysfunction. About Aspargo Laboratories, Inc.Aspargo Laboratories, Inc., located in Englewood Cliffs, New Jersey, is a clinical stage, specialty pharmaceutical company focused on developing an oral spray formulation of sildenafil citrate, the active ingredient in VIAGRA®.
Aspargo is the US and international licensee of the patent rights covering Sildenafil Oral Spray from Farmalider, S.A. of Madrid, Spain ( Aspargo’s leadership team has a proven background and a track record in successful drug product development, regulatory approval and commercialization. For additional information, please visit our website at Forward Looking StatementsThis press release contains forward-looking statements made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management’s current knowledge, assumptions, judgment and expectations regarding future performance or events, they give no assurance that such expectations will prove to be correct. Forward-looking statements are subject to a number of risks and uncertainties, but not limited to, our liability to obtain additional capital on acceptable terms, or at all, including additional capital which will be necessary to complete the clinical trials, delays caused by institutional review boards or regulatory agencies, enrollments, shortage of clinical trial supplies, dependence on clinical trial collaborators, loss of any executive officers or key personnel or consultants. Your heart has to work very hard to pump blood into your lungs.